← Open Payments lookup

GERARDO CABRERA CONTRERAS: Open Payments

NPI 1972239176 · WALNUT HILLS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,150 in 41 payments from 10 companies in 2025. Trend: 2023 $2,497 · 2024 $2,367 · 2025 $1,150

Food & beverage: $1,146Education: $4
CompanyPaymentsAmount
ABBVIE INC.13$286
Otsuka America Pharmaceutical, Inc.3$257
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$192
Neurocrine BioSciences, Inc.6$154
Teva Pharmaceuticals USA, Inc.5$123
Janssen Pharmaceuticals, Inc4$61
Vanda Pharmaceuticals Inc.1$22
Lundbeck LLC1$21
Alkermes, Inc.1$19
Noven Therapeutics, LLC1$14

Products named: VRAYLAR, CAPLYTA, INGREZZA, ABILIFY MAINTENA, REXULTI, AUSTEDO XR, INVEGA SUSTENNA, UZEDY.

Industry payments across OH — which companies pay providers there.